Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease · 2024-01 · Volume 19 · 243-254
DOI: 10.2147/copd.s433583 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024-01. Verfasst von Eun Kyung Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Atrial Fibrillation, Myocardial Ischemia, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Background
COPD coexists with many concurrent comorbidities. Cardiovascular complications are deemed to be major causes of death in COPD. Although inhaler therapy is the main therapeutic intervention in COPD, cardiovascular events accompanying inhaler therapy require further investigation. Therefore, this study aimed to investigate new development of cardiovascular events according to each inhaler therapy and comorbidities.
Methods
This study analyzed COPD patients (age ≥ 40 years, N = 199,772) from the Health Insurance Review and Assessment Service (HIRA) database in Korea. The development of cardiovascular events, from the index date to December 31, 2020, was investigated. The cohort was eventually divided into three arms: the LAMA/LABA group (N = 28,322), the ICS/LABA group (N = 11,812), and the triple group (LAMA/ICS/LABA therapy, N = 6174).
Results
Multivariable Cox analyses demonstrated that, compared to ICS/LABA therapy, triple therapy was independently associated with the development of ischemic heart disease (HR: 1.22, 95% CI: 1.04-1.43), heart failure (HR: 1.45, 95% CI: 1.14-1.84), arrhythmia (HR: 1.72, 95% CI: 1.41-2.09), and atrial fibrillation/flutter (HR: 2.31, 95% CI: 1.64-3.25), whereas the LAMA/LABA therapy did not show a significant association. Furthermore, emergency room visit during covariate assessment window was independently associated with the development of ischemic heart disease, heart failure, arrhythmia, and atrial fibrillation/flutter (p < 0.05).
Conclusion
Our data suggest that cardiovascular risk should be considered in COPD patients receiving triple therapy, despite the confounding bias resulting from disparities in each group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
- Department of Neurology, McGovern Medical School at UTHealth, Houston, TX, USA.
- Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
- Office of Biostatistics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Republic of Korea.
ORCID-Profile: Eun Kyung Kim, Jae Seung Lee, Hye Sook Choi, Seung Soo Sheen, Chin Kook Rhee, Kwang Ha Yoo
Zitieren
APA
Kim, E. K., Lee, E., Park, J. E., Lee, J. S., Choi, H. S., Park, B., Sheen, S. S., Park, K. J., Rhee, C. K., Lee, S. Y., Yoo, K. H., & Park, J. H. (2024). Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 243-254. https://doi.org/10.2147/copd.s433583
Vancouver
Kim EK, Lee E, Park JE, Lee JS, Choi HS, Park B, et al. Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:243-254. doi:10.2147/copd.s433583
BibTeX
@article{Kim2024,
author = {Kim, Eun Kyung and Lee, Eunyoung and Park, Ji Eun and Lee, Jae Seung and Choi, Hye Sook and Park, Bumhee and Sheen, Seung Soo and Park, Kwang Joo and Rhee, Chin Kook and Lee, Sang Yeub and Yoo, Kwang Ha and Park, Joo Hun},
title = {Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
volume = {Volume 19},
pages = {243--254},
doi = {10.2147/copd.s433583}
}
EUVIMED